BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37821193)

  • 1. Type I Interferonopathies: A Clinical Review.
    Wang CS
    Rheum Dis Clin North Am; 2023 Nov; 49(4):741-756. PubMed ID: 37821193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferonopathies: a novel set of inborn errors of immunity.
    Crow YJ
    Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aicardi-Goutières syndrome: A monogenic type I interferonopathy.
    Liu A; Ying S
    Scand J Immunol; 2023 Oct; 98(4):e13314. PubMed ID: 37515439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type I interferonopathies].
    Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
    Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
    Yu ZX; Song HM
    World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aicardi-Goutières syndrome and the type I interferonopathies.
    Crow YJ; Manel N
    Nat Rev Immunol; 2015 Jul; 15(7):429-40. PubMed ID: 26052098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic interferonopathies: An overview.
    Eleftheriou D; Brogan PA
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies in Aicardi-Goutières syndrome.
    Crow YJ; Vanderver A; Orcesi S; Kuijpers TW; Rice GI
    Clin Exp Immunol; 2014 Jan; 175(1):1-8. PubMed ID: 23607857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
    Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
    Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac valve involvement in
    Crow Y; Keshavan N; Barbet JP; Bercu G; Bondet V; Boussard C; Dedieu N; Duffy D; Hully M; Giardini A; Gitiaux C; Rice GI; Seabra L; Bader-Meunier B; Rahman S
    J Med Genet; 2020 Jul; 57(7):475-478. PubMed ID: 31772029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dirty Fish Versus Squeaky Clean Mice: Dissecting Interspecies Differences Between Animal Models of Interferonopathy.
    Rutherford HA; Kasher PR; Hamilton N
    Front Immunol; 2020; 11():623650. PubMed ID: 33519829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mutant
    Withers SE; Rowlands CF; Tapia VS; Hedley F; Mosneag IE; Crilly S; Rice GI; Badrock AP; Hayes A; Allan SM; Briggs TA; Kasher PR
    Front Immunol; 2023; 14():1100967. PubMed ID: 36949945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferonopathies in pediatric rheumatology.
    Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.
    Galli J; Gavazzi F; De Simone M; Giliani S; Garau J; Valente M; Vairo D; Cattalini M; Mortilla M; Andreoli L; Badolato R; Bianchi M; Carabellese N; Cereda C; Ferraro R; Facchetti F; Fredi M; Gualdi G; Lorenzi L; Meini A; Orcesi S; Tincani A; Zanola A; Rice G; Fazzi E;
    Medicine (Baltimore); 2018 Dec; 97(52):e13893. PubMed ID: 30593198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
    Behrendt R; Roers A
    Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Editing in Interferonopathies.
    Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
    Methods Mol Biol; 2021; 2181():269-286. PubMed ID: 32729086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies.
    Pescarmona R; Belot A; Villard M; Besson L; Lopez J; Mosnier I; Mathieu AL; Lombard C; Garnier L; Frachette C; Walzer T; Viel S
    Cytokine; 2019 Jan; 113():446-452. PubMed ID: 30413290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "Catatonia in a Patient with Aicardi-Goutières Syndrome Efficiently Treated with Immunoadsorption".
    Varesio C; De Giorgis V; Fazzi E; Orcesi S
    Schizophr Res; 2020 Oct; 224():188-189. PubMed ID: 32928619
    [No Abstract]   [Full Text] [Related]  

  • 19. Type I interferonopathies: mendelian type I interferon up-regulation.
    Crow YJ
    Curr Opin Immunol; 2015 Feb; 32():7-12. PubMed ID: 25463593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments in Aicardi-Goutières syndrome.
    Crow YJ; Shetty J; Livingston JH
    Dev Med Child Neurol; 2020 Jan; 62(1):42-47. PubMed ID: 31175662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.